Active ingredients: Aciclovir
Zovirax I.V. 250 mg.
Zovirax I.V. 500 mg.
Intravenous injection.
250 mg aciclovir or 500 mg aciclovir in each vial.
Excipients with known effect: Sodium hydroxide
For the full list of excipients, see section 6.1.
Acyclovir is an antiviral agent with activity against herpes simplex virus and varicella-zoster virus. Acyclovir inhibits the DNA polymerase of the virus, preventing further proliferation.
Sodium hydroxide (used to adjust pH)
Type I glass vials closed with butyl or bromobutyl rubber stoppers secured by aluminium collars.
17 ml-nominal capacity of vial containing 250 mg aciclovir.
25 ml-nominal capacity of vial containing 500 mg aciclovir.
The Wellcome Foundation Ltd., 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom
Trading as: GlaxoSmithKline UK, Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Date of first authorisation: 6 April 1982
Date of last renewal: 9 June 1997
PL 00003/0159